ESMO pays tribute to Professor José Baselga

por Peters, S., Tabernero, J., Cervantes, A., Banerjee, S., Giuliani, R., Lordick, F.
Publicado 2021

ESMO pays tribute to Professor José Baselga

por Peters, S., Tabernero, J., Cervantes, A., Banerjee, S., Giuliani, R., Lordick, F.
Publicado 2021

Evenamide, as an add-on to antipsychotics, benefits patients with treatment resistant schizophrenia: 6-month interim results from the first 100 patients in an ongoing international...

por Anand, R., Hartman, R., Lucini, V., Giuliani, R., Turolla, A., Chinellato, G.
Publicado 2023

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate

por Garassino, M.C., Vyas, M., de Vries, E.G.E., Kanesvaran, R., Giuliani, R., Peters, S.
Publicado 2021

The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer

por Delgado, J., Vleminckx, C., Sarac, S., Sosa, A., Bergh, J., Giuliani, R., Enzmann, H., Pignatti, F.
Publicado 2021

Monkeypox epidemic in prisons: How to prevent it?

por Cocco, N., Sebastiani, T., Giuliani, R., Cereda, D., D'Arminio Monforte, A., Tavoschi, L., Ranieri, R.
Publicado 2022

Tobacco cessation and the role of ESMO and medical oncologists: addressing the specific needs of cancer patients in times of the COVID-19 pandemic

por Krech, R., Peters, S., Kroemer, H., Fu, D., Giuliani, R., Sehouli, J., Ilbawi, A., Prasad, V., Ullrich, A.
Publicado 2023

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain

por Roitberg, F., Amaral, T., Cherny, N.I., Giuliani, R., Latino, N.J., Galotti, M., Bricalli, G., Curigliano, G., Pentheroudakis, G., Trapani, D.
Publicado 2023

Distribution of the workforce involved in cancer care: a systematic review of the literature

por Trapani, D., Murthy, S.S., Boniol, M., Booth, C., Simensen, V.C., Kasumba, M.K., Giuliani, R., Curigliano, G., Ilbawi, A.M.
Publicado 2021

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

por Borgohain, Rupam, Szasz, J, Stanzione, P, Meshram, C, Bhatt, M, Chirilineau, D, Stocchi, F, Lucini, V, Giuliani, R, Forrest, E, Rice, P, Anand, R
Publicado 2014

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

por Castelo-Branco, L., Awada, A., Pentheroudakis, G., Perez-Gracia, J.L., Mateo, J., Curigliano, G., Banerjee, S., Giuliani, R., Lordick, F., Cervantes, A., Tabernero, J., Peters, S.
Publicado 2021

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines

por Zarkavelis, G., Amylidi, A.L., Verbaanderd, C., Cherny, N.I., Metaxas, Y., de Vries, E.G.E., Zygoura, P., Amaral, T., Jordan, K., Strijbos, M., Dafni, U., Latino, N., Galotti, M., Lordick, F., Giuliani, R., Pignatti, F., Pentheroudakis, G.
Publicado 2022

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

por Casali, P. G., Bruzzi, P., Bogaerts, J., Blay, J.-Y., Aapro, M., Adamous, A., Berruti, A., Blay, J.-Y., Bogaerts, J., Bressington, J., Bruzzi, B., Capocaccia, R., Cardoso, F., Casali, P. G., Celis, J. E., Cervantes, A., Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., De Boltz, D., De Lorenzo, F., Dei Tos, A. P., Gatta, G., Geissler, J., Giuliani, R., Grande, E., Gronchi, A., Jezdic, S., Jonsson, B., Jost, L., Keulen, H., Lacombe, D., Lamory, G., Le Cam, Y., Leto di Priolo, S., Licitra, L., Macchia, F., Margulies, A., Marreaud, S., McVie, G., Narbutas, S., Oliver, K., Pavlidis, N., Pelouchova, J., Pentheroudakis, G., Piccart, M., Pierotti, M. A., Pravettoni, G., Redmond, K., Riegman, P., Ruffilli, M. P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V., Trama, A., Van Belle, S., Vassal, G., Wartenberg, M., Watts, C., Wilson, A., Yared, W.
Publicado 2015